Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion ...

The deal, announced on March 6, would allow Sycamore Partners to take Walgreens private. The drug-store chain expects the transaction to close in the third or fourth quarter of 2025.

Walgreens Boots Alliance (WBA) announced that at the Company’s Special Meeting of Shareholders, WBA shareholders approved the previously announced acquisition of the Company by entities affiliated ...

Walgreens Boots Alliance shareholders gave the thumbs up to the private-equity buyout by Sycamore Partners, with about 96% of ...

Private-equity giant Sycamore Partners is exploring a possible bid to buy Macy’s – even as the iconic retail chain this week rejected an unsolicited offer from another bidding group, The ...

Private equity firm Sycamore Partners has entered into a definitive agreement with Walgreens Boots Alliance to acquire the struggling retail pharmacy chain. Sycamore has agreed to pay $11.45 per ...

Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased competition from online retailers like Amazon. It remains to be seen ...

Sycamore Partners called her back to Talbots with its acquisition in 2012. According to a presentation she made to Syracuse University’s Whitman School of Management in 2020, ...

The deal, announced on March 6, would allow Sycamore Partners to take Walgreens private. The drug-store chain expects the transaction to close in the third or fourth quarter of 2025.

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the "Company" or "WBA") today announced that at the Company’s Special Meeting of Shareholders (the "Special Meeting"), WBA shareholders approved the ...

Walgreens Boots Alliance shareholders have overwhelmingly approved the company’s pending acquisition by Sycamore Partners. According to preliminary results, approximately 96% of votes cast at ...

Walgreens' $10B sale to Sycamore Partners ends a long decline for one of Chicago’s most iconic companies — and raises questions about what comes next.